Clin2
NCT04259359Possibly a fitRecruiting

Bee sting allergy trial for people starting venom immunotherapy

Bee Venom Allergy

Part of Immune system & allergy clinical trials.

This trial studies whether having strong reactions to a specific bee venom protein can make venom immunotherapy less effective. It may help doctors better predict who is at higher risk for therapy failure after bee stings.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
266 people
Ages
18 years to 70 years
Study type
Observational

Who can take part

  • You are between 18 and 70 years old.
  • You have had a whole-body (systemic) allergic reaction to a bee sting before (at least grade I).
  • You are planning to receive bee venom immunotherapy (treatment that helps your body tolerate bee venom).
  • You do not have medical reasons that make venom immunotherapy unsafe for you (no contraindications to VIT).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04438525Recruiting
BAT test to replace sting challenge in venom allergy care

This study looks at whether a BAT (a blood test) can stand in for sting/venom “challenges” for people already receiving venom immunotherapy. If it works, it could help patients avoid more risky or uncomfortable challenge procedures while still checking whether treatment is working.

Graz
NCT06790368Recruiting
Venom allergy treatment in real-life settings

This trial tests a venom immunotherapy for people allergic to bee or wasp stings. It aims to see how well the treatment works in everyday medical practice.

Alcorcón, Madrid
NCT07309822Recruiting
Beltaven® venom allergy immunotherapy study

This study tests a treatment called Beltaven® for people with severe allergic reactions to bee, wasp, or hornet stings. It aims to see if the treatment is safe and helps prevent future reactions.

Barcelona, Barcelona
NCT06782217Recruiting
Safety study of bee and wasp venom allergy shots

This study monitors the safety of venom immunotherapy (allergy shots) for people with bee or wasp sting allergies. If you are starting this treatment, researchers will track how well you tolerate it over time.

Ferrol, A Coruña
NCT06156046Recruiting
Understanding bee venom tolerance in beekeepers

This study looks at how beekeepers develop tolerance to bee venom over time, comparing people who are new to beekeeping, experienced beekeepers without allergies, and beekeepers who have had a recent allergic reaction. If you fall into one of these groups, you may be able to join and help researchers understand how the immune system adapts to bee stings.

Plymouth, Devon
NCT07721233Not yet recruiting
Can virtual reality change immune responses in people with allergies?

This study tests if virtual reality experiences can affect the immune system in people with bee or wasp venom allergies. It may help understand new ways to treat allergies.

Hear when a new Bee Venom Allergy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.